BC Advantage - 2022 Issue 9
AMA Announces CPT Update for COVID-19 Boosters Adapted to OmicronÂ
Subscribe or sign in to view the full article.
Article Overview
This article explains an AMA editorial update to CPT that adds new coding for updated COVID-19 booster products adapted to Omicron subvariants. It is aimed at coders, billing staff, clinicians, and anyone tracking vaccine reporting changes. The article also describes the broader CPT editorial process and points readers to AMA resources for identifying the appropriate vaccine and administration code pairings.
Why This Topic Matters
It helps organizations stay current with vaccine coding and reporting changes tied to updated COVID-19 booster products and FDA authorization timing.
Article Sections
-
AMA announces CPT update for COVID-19 boosters adapted to Omicron
Overview of the editorial update to CPT and the general purpose of the new vaccine-related coding changes.
-
Effective dates and authorization status
Discussion of when the new codes may be used and how FDA authorization status relates to the update.
-
New product and administration codes
A structured listing of the updated vaccine products and associated administration codes by manufacturer and age group.
-
Coding support and CPT editorial process
Information about AMA resources for identifying vaccine code combinations and the broader CPT editorial process.
What You Will Learn
- How the CPT update is framed in relation to updated COVID-19 booster products.
- Which general types of vaccine coding changes were introduced.
- What supporting resources are referenced for vaccine code identification.
- How the CPT editorial process is described in the context of keeping code content current.
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Healthcare compliance teams
- Clinicians
- Practice managers
- Public health reporting staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com